Breast cancer remains the second leading cause of cancer death for women in the United
States. 1 In the United States in 2022, the American Cancer Society (ACS) estimates that …

This systematic review was conducted to investigate predictors of treatment refusal in
colorectal cancer (CRC) patients. An understanding of these predictors would inform …

Objective Patients diagnosed with colorectal cancer living in more deprived areas
experience worse survival than those in more affluent areas. Those living in more deprived …

PURPOSE: As outcomes improve in early-stage breast cancer, clinical trials are undergoing
a paradigm shift from intensification trials (more therapy) to improve survival to optimization …

Background Tumor biomarkers are regularly used to guide breast cancer treatment and
clinical trial enrollment. However, there remains a lack of knowledge regarding physicians' …

Background Immune checkpoint inhibitors have transformed the treatment landscape of
many cancers, including melanoma and renal cell carcinoma (RCC). Randomised trials are …

Evidence-based reductions in cancer treatment that still preserve outcomes can result in an
improved quality of life for patients and optimized healthcare resourcing. Using melanoma …

Patients with breast cancer, including those with early-stage disease, have historically been
subject to invasive surgical procedures, medical therapies, and radiation therapy. However …

Purpose To explore the unmet supportive care needs of patients with advanced cancer
receiving immune-biological and precision (IBP) therapies. Methods We conducted semi …

Background Cancer recurrence after treatment is a concern for patients and oncologists
alike. The movement towards treatment optimization, with trials testing less than the current …